Costa, I. et al. (2022) “Metastatic Castration-Resistant Prostate Cancer with BRCA2 Mutation: The Challenge Incorporating PARP Inhibitors and Platinum in Treatment Sequencing”, European Journal of Case Reports in Internal Medicine, 9(5). doi:10.12890/2022_003331.